FDA PMA FDA Class 2 Approved 🇺🇸 United States

Hepatitis A Test (Antibody And Igm Antibody)

PMA: P890019 · Supplement: S005 · Decision Sep 22, 1998
Classifications
1
FEI Numbers
24
Registration Numbers
24

Basic Information

Device Name
Hepatitis A Test (Antibody And Igm Antibody)
Trade Name
AB-HAVK, ETI-AB-HAVK, ETI-AB-HAVK PLUS
PMA Number
P890019
Supplement Number
S005
Device Class
FDA Class 2
Product Code
LOL
Generic Name
Hepatitis a test (antibody and igm antibody)
Regulation Number
866.3310
Medical Specialty
Microbiology
Advisory Committee
Microbiology
Decision
Approved
Decision Code
APPR
Decision Date
September 22, 1998
Date Received
November 24, 1997
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Approval for a change in the Enzyme tracer and Tracer Diluent from an IgG (Human) anti-HAV-HRP to a Fab anti-HAV (Mab)-HRP; a change in the Positive Control and Negative Control materials to human source sera; the elimination of the mercury preservative in the reagents; and the addition of a neutralizing solution, incubation buffer and a Calibrator reagent. The device, as modified, will be marketed under the trade name DiaSorin ETI-AB-HAVK PLUS and is intended for the qualitative determination of total antiboides to hepatitis A virus (anti-HAV) in human serum or plasma. This assay is indicated for use as an aid in the dignosis of current or previous hepatitis A virus infection and as an aid in the diagnosis of current or previous hepatitis A virus infection and as an aid in the identification of HAV-susceptible individuals for vaccination.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LOL Hepatitis A Test (Antibody And Igm Antibody)